Table 4.
Baseline | Time 0, min Post | Time 2, min Post | Time 4, min Post | Time 15, min Post | Time 30, min Post | Time 45, min Post | |
---|---|---|---|---|---|---|---|
[], nmol/l*# | |||||||
Placebo | |||||||
Pre | 87.3 ± 7.6 | 63.5 ± 4.2 | 70.9 ± 3.4 | 68.3 ± 4.8 | 72.8 ± 10.8 | 69.0 ± 5.7 | 71.0 ± 7.4 |
Post | 104.2 ± 13.5 | 91.3 ± 9.7 | 86.2 ± 9.1 | 83.8 ± 11.3 | 88.7 ± 7.6 | 82.3 ± 6.5 | 76.5 ± 6.9 |
MC | |||||||
Pre | 82.1 ± 10.0 | 80.7 ± 11.1 | 74.2 ± 11.3 | 71.9 ± 10.1 | 68.2 ± 14.9 | 64.2 ± 11.8 | 66.8 ± 10.1 |
Post | 83.2 ± 10.5 | 65.6 ± 7.3 | 77.7 ± 8.6 | 70.2 ± 6.4 | 81.1 ± 7.3 | 74.2 ± 9.4 | 77.0 ± 10.7 |
[], µmol/l* | |||||||
Placebo | |||||||
Pre | 32.8 ± 3.9 | 29.7 ± 3.6 | 28.6 ± 3.5 | 28.7 ± 3.3 | 27.7 ± 2.9 | 27.9 ± 2.9 | 27.2 ± 3.0 |
Post | 27.3 ± 2.6 | 25.7 ± 3.0 | 26.8 ± 3.3 | 25.9 ± 2.4 | 25.7 ± 2.7 | 24.4 ± 2.8 | 25.8 ± 2.7 |
MC | |||||||
Pre | 27.6 ± 4.9 | 24.8 ± 4.4 | 26.2 ± 4.7 | 25.8 ± 4.8 | 25.6 ± 4.6 | 25.0 ± 4.5 | 24.7 ± 4.1 |
Post | 29.5 ± 5.2 | 28.2 ± 4.9 | 29.3 ± 4.9 | 27.9 ± 4.9 | 26.8 ± 4.7 | 26.6 ± 4.4 | 26.3 ± 4.4 |
Values are expressed as means ± SE. Plasma [] and [] measured 15 min before 20-min occlusion (baseline), and immediately, 2, 4, 15, 30, and 45 min after reperfusion, before, and after placebo or Montmorency cherry (MC) supplementation.
Main effect of time P < 0.001.
Three-way interaction effect.